pentoxifylline has been researched along with Developmental Disabilities in 1 studies
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results suggest that combination of atypical antipsychotic medications and pentoxifylline might have synergistic effects in treatment of behavioral problems of children with autism." | 9.14 | Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. ( Akhondzadeh, S; Fallah, J; Forghani, S; Ghanizadeh, A; Imani, R; Mohammadi, M; Mohammadi, MR; Mohebbi-Rasa, S; Raznahan, M; Rezazadeh, SA; Salehi, B, 2010) |
| "The results suggest that combination of atypical antipsychotic medications and pentoxifylline might have synergistic effects in treatment of behavioral problems of children with autism." | 5.14 | Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. ( Akhondzadeh, S; Fallah, J; Forghani, S; Ghanizadeh, A; Imani, R; Mohammadi, M; Mohammadi, MR; Mohebbi-Rasa, S; Raznahan, M; Rezazadeh, SA; Salehi, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhondzadeh, S | 1 |
| Fallah, J | 1 |
| Mohammadi, MR | 1 |
| Imani, R | 1 |
| Mohammadi, M | 1 |
| Salehi, B | 1 |
| Ghanizadeh, A | 1 |
| Raznahan, M | 1 |
| Mohebbi-Rasa, S | 1 |
| Rezazadeh, SA | 1 |
| Forghani, S | 1 |
1 trial available for pentoxifylline and Developmental Disabilities
| Article | Year |
|---|---|
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
Topics: Antipsychotic Agents; Autistic Disorder; Behavioral Symptoms; Child; Child, Preschool; Developmental | 2010 |